Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 First Implants of Gore's VIAFORT Vascular Stent - Medical Product Outsourcing
OEM News

First Implants of Gore’s VIAFORT Vascular Stent

Treats inferior vena cava (IVC) occlusive disease with or without iliofemoral vein involvement.

W.L. Gore & Associates (Gore) has achieved the first implants of its investigational GORE VIAFORT vascular stent as part of its recently initiated GORE VIAFORT device pivotal clinical study to treat inferior vena cava (IVC) occlusive disease with or without iliofemoral vein involvement.
 
The first-in-human procedures were completed at the Auckland City Hospital in Grafton, Auckland, New Zealand, by interventional radiologist Andrew Holden, MD, Director of Regional Interventional Radiology at the Auckland Regional Public Health Service.
 
“This first implantation is an important milestone for venous occlusive disease treatment,” Dr. Holden told the press. “Right now, there are limited device options indicated for both IVC and iliofemoral venous disease. Implanting the GORE VIAFORT Vascular Stent in patients represents a significant step forward in research.”
 
The VIAFORT vascular stent uses Gore’s expanded polytetrafluoroethylene (PTFE) tech with a single-wound nitinol frame. The clinical study is assessing the device in a treatment range of 10-28 mm diameter for iliofemoral veins and the IVC.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters